Syncromune® Inc. to Present Initial Clinical Data from SYNC-T™ SV-102 Phase 1 as a Late-Breaker at the American Association for Cancer Research Annual Meeting 2024

Home Science Platform Pipeline Publications Trials Resources Current Trials Expanded Access About Company Leadership Board of Directors Scientific Advisory Board Careers Newsroom Contact Home Science Platform Pipeline Publications Trials Resources Current Trials Expanded Access About Company Leadership Board of Directors Scientific Advisory Board Careers Newsroom Contact

The release as fetched from its publisher. syncromune.com ↗